Biologics 2023

Biologics 2023

Event Date: March 30, 2023 - March 31, 2023

Location: United Kingdom, London

Website: Link

Biologics 2023: Oxford Global’s 16th Annual Proteins & Antibodies Congress, 30 – 31 March 2023, London, UK will be attended by over 400 visionary leaders to network about the latest innovations in the field.  

With a revamped agenda, visionary leaders will be looking at novel computational approaches & tools, AI/ML utilisation as well as advanced engineering methods, bioanalysis and cell engagers.

Featuring a pre-event focus day on 29th March with the opening event keynote address on ‘Antibody Discovery & Engineering In A Chronic Disease Management Perspective; delivered by Erik Vernet, Director of Antibody Technology, Novo Nordisk.  


The event will be looking at the following main themes:  

  • Day 1 Track 1: Antibody-Based Molecular Engineering 
  • Day 1 Track 2: Emerging Techniques for Bioanalysis & Characterisation and Quality Control Systems 
  • Day 2 Track 1 – Computational Tools, Structural Approaches & Automation in Engineering 
  • Day 2 Track 2 – Multi Specific Antibodies, Cell Engagers & Other New Modalities 


Key Speakers Include:  

  • Aneesh Karatt Vellatt, Chief Scientific Officer, Maxion Therapeutics 
  • Annelise Vuidepot, Chief Technology Officer, Immunocore 
  • Dan Snell, Vice President, Translational Sciences, Numab Therapeutics 
  • Stefan Warmuth, Vice President, Protein Engineering & CMC, Numab Therapeutics 
  • Colette Johnston, Vice President, Discovery, Crescendo Biologics 
  • Amita Datta-Mannan, Associate Vice President, Eli Lilly & Company 
  • Samuel Pine, Senior Director and Head of Bioanalysis and Immunogenicity, Sanofi 
  • Maria Knudsen, Director, Salipro Biotech 
  • Ryan Fiehler, Associate Director, Discovery, F-star Therapeutics 
  • Stefan Grüner, Associate Director of Protein Engineering, Pieris Pharmaceuticals 


Featuring a series of dedicated interactive sessions:

  • Panel Discussion: Different Technologies In Antibody Engineering  
  • Panel Discussion: Immunogenicity Of New Modalities 
  • Roundtable: Influence Of Biologics Physio-Chemical Properties On PK & Disposition  
  • Roundtable: Bioassay Strategies For Biologics Identification 
  • Workshop: Integration Of Data For AI/ML & Structural Modelling 
  • Workshop: T Cell Engager Biology And Therapeutic Strategies  


Co-located with the Peptides & Oligonucleotides Congress. For more information contact  

← Back to List of Events